Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits.
- Author:
Hong WANG
1
;
Hong WANG
;
Qun-you TAN
;
Li ZHANG
;
Xun-guan CHENG
;
Jing-qing ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Administration, Oral; Animals; Biological Availability; Female; Male; Pyridostigmine Bromide; administration & dosage; blood; pharmacokinetics; Rabbits; Tablets; Therapeutic Equivalency
- From: Journal of Southern Medical University 2011;31(10):1778-1780
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo compare the pharmacokinetic parameters of pyridostigmine bromide dispersible tablets and common tablets in rabbits.
METHODSTwelve rabbits were given an oral dose (60 mg) of pyridostigmine bromide dispersible tablets or common tablets in a randomized crossover study. The plasma concentration of pyridostigmine bromide was determined by reversed-phase ion pair chromatography. The pharmacokinetic parameters were calculated using DAS2.1.1 software.
RESULTSThe pharmacokinetic parameters showed no significant differences in rabbit plasma between pyridostigmine bromide dispersible tablets and common tablets. The two tablets had a C(max) of 1.83∓0.08 mg·L(-1) and 1.68∓0.03 mg·L(-1), tmax of 2.33∓0.41 h and 2.58∓0.20 h, AUC(0-24) of 15.50∓0.62 mg·h·L(-1) and 15.14∓0.30 mg·h·L(-1), AUC(0-∞) of 15.82∓0.70 mg·h·L(-1) and 15.57∓0.32 mg·h·L(-1), respectively. The relative bioavailability F(0-24) was 102.38% and F(0-∞) was 101.61% for the dispersible tablets.
CONCLUSIONThe two tablets are bioequivalent in rabbits.